Oh No – Here Comes 2028
Destructive Environmentalists
Don’t Be Fooled By The Democrat Great Reset
Schumer to GOP: Please Don't Do What We Were Going to Do to...
Biden Was the Fluke in 2020, Not Trump in 2016
Breaking Up Google Will Be a Great American Catastrophe
TV Stars Mock the Tiny Threat of Trans Women in Sports
Young, Black, Hispanic Americans Would Opt Out of Social Security Even If It...
Kamala's Defeat Ushers in New, Law-and-Order Future for Cities
The New FCC Chairman's Agenda Contradicts Conservative Principles
Julian Harston Reveals the Truth Behind the Sahara Issue
Pay for All Americans’ Tax Cuts with a Tax on Illegal Immigrants
Deep State Invites Nuclear War
Schumer’s Misguided Plan to Hand AI Regulation to the Administrative State
Bureaucratic Luddites Are Coming for AI
Tipsheet

This British Health Official's Take on Transgender 'Chestfeeding' Is Something Else

AP Photo/James B. Hale

A health official in the United Kingdom claimed that breast milk from biological males who “transitioned” to live as women is just as healthy as breast milk from a female who has given birth. 

Advertisement

The Telegraph reported this week that a leaked letter from a University Hospitals Sussex NHS Foundation Trust medical director claims that breast milk produced by “trans women” as a result of taking so-called “gender-affirming” drugs is “comparable to that produced [by a mother] following the birth of a baby.”

The hospital uses “woke” gender-neutral language like “chestfeeding” and “human milk” instead of “breastfeeding” and “breastmilk.” 

The letter reportedly outlined how trans women can produce breast milk through “induced lactation” (via the New York Post):

The hospital, which claims it was the first to use the gender-inclusive term “chestfeeding,” explained that transgender women can develop lactation partly by taking the hormone progestin, which helps develop a biological male’s already existent but typically dormant milk-producing glands.

Drugs such as domperidone, which is often given to biological women struggling to breastfeed, then help stimulate the production of prolactin, a separate hormone that tells the body to produce milk.

While domperidone, also known by the brand name Motilium, was not intended for this use, USHT said the practice is safe, even though the medication could be transferred to the baby through breastfeeding and has the potential to affect the baby’s heart.

Advertisement

Lottie Moore, who works at the think tank Policy Exchange, told The Telegraph that the letter is “unbalanced” and “naïve in its assertion that the secretions produced by a male on hormones can nourish an infant in the way a mother’s breast milk can.” 

“A child’s welfare must always take precedence over identity politics and contested belief systems that are not evidence-based. The NHS should not be indulging in this nonsense,” Moore added.

The hospital trust is known for being progressive when it comes to the LGBTQ+ agenda, and has reworked its guidelines and language to support “trans and non-binary birthing people.”

The Post noted that USHT reportedly removed its webpage about transgender breastfeeding guidance and now links to a group called La Leche League, which reportedly “supports everyone who wants to breastfeed or chestfeed in reaching their goals.” 

However, a representative for the hospital told the outlet that it still “stand[s] by the facts of the letter and cited evidence supporting them.”

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement